Development of multidrug resistant tuberculosis in Bangladesh: A case-control study on risk factors

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Rifat, Mahfuza ^a,b   Milton, Abul Hasnat ^a   Hall, John ^a   Oldmeadow, Christopher ^a   Islam, Md Akramul ^b   Husain, Ashaque ^c   Akhanda, Md Wahiduzzaman ^c   Siddiquea, Bodrun Naher ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^c National Tuberculosis Control Programme Directorate General of Health Services ^*  (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BANGLADESH; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; INFECTION SENSITIVITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIDRUG RESISTANT TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; RISK FACTOR; SMOKING; TUBERCULOSIS; MIDDLE AGED; STATISTICAL MODEL; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADULT; BANGLADESH; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84929940297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105214     Document Type: Article

References (36)

1. World Health Organization (2013) Global Tuberculosis Report 2013. Geneva.
2. World Health Organization (2011) Towards the universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015,WHO progress report. Geneva.
3. Caminero JA, editor (2013) Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. Paris, France: International Union Against Tuberculosis and Lung Disease.
4. World Health Organization (2011) The Global Plan to Stop TB, Transforming the Fight towards Elimination of Tuberculosis. Geneva.
5. World Health Organization (2008) Anti-Tuberculosis Drug Resistance in the World, 4th Global Report. Geneva.
6. UNAIDS (2013) Global Report, UNAIDS Report on the Global AIDS Epidemic 2013. Geneva.
7. Caminero JA (2010) Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 14: 382-390.
8. Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, et al. (2009) Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis 13: 68-73.
9. Faustini A, Hall AJ, Perucci CA (2006) Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61: 158-163. (Pubitemid 43235434)
10. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, et al. (2001) Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 5: 887-893. (Pubitemid 32976631)
11. Diande S, Sangare L, Kouanda S, Dingtoumda BI, Mourfou A, et al. (2009) Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa. Microb Drug Resist 15: 217-221.
12. Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, et al. (2003) Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 3: 183-188. (Pubitemid 37168746)
13. Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A, et al. (2010) Prevalence of multi-drugresistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg 104: 511-517.
14. Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, et al. (2005) A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 11: 62-67. (Pubitemid 40365847)
15. Shen X, DeRiemer K, Yuan ZA, Shen M, Xia Z, et al. (2009) Drug-resistant tuberculosis in Shanghai China, 2000-2006: prevalence, trends and risk factors. Int J Tuberc Lung Dis 13: 253-259.
16. Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, et al. (2008) Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 12: 1065-1070.
17. Suarez-Garcia I, Rodriguez-Blanco A, Vidal-Perez JL, Garcia-Viejo MA, Jaras-Hernandez MJ, et al. (2009) Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis 28: 325-330.
18. World health Organization, International Union Against Tuberculosis and Lung Disease (2007) A WHO/The Union Monograph on TB and Tobacco control, Joining efforts to control two related global epidemics. Geneva.
19. Kim HR, Hwang SS, Kim EC, Lee SM, Yang SC, et al. (2011) Risk factors for multidrug-resistant bacterial infection among patients with tuberculosis. J Hosp Infect 77: 134-137.
20. Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, et al. (2008) Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 40: 888-893.
21. Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, et al. (2010) Predictors of multidrug-and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One 5: e15735.
22. Zaman K, Rahim Z, Yunus M, Arifeen S, Baqui AH, et al.(2005) Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scand J Infect Dis 37: 21-26. (Pubitemid 40227736)
23. Farmer P, Bayona J, Becerra M (2001) Multidrug resistant tuberculosis and the need for biosocial perspectives. Int J Tuberc Lung Dis 5: 885-6. (Pubitemid 32976630)
24. Suchindran S, Brouwer ES, Van Rie A (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One 4: e5561.
25. Flora MS, Amin MN, Karim MR, Afroz S, Islam S, et al. (2013) Risk factors of multi-drug-resistant tuberculosis in Bangladeshi population: a case control study. Bangladesh Medical Research Council Bulletin 39: 34-41.
26. National TB Control Programme DGoHS, Bangladesh (2012) Tuberculosis Control in Bangladesh, Annual Report. Dhaka.
27. National TB Control Programme DGoHS, Bangladesh (2012) Operation manual for management of Multidrug-resistant TB(MDR TB). 2nd ed. Dhaka.
28. National TB Control Programme DGoHS, Bangladesh (2013) First Bangladesh National Tuberculosis Drug Resistance Survey 2010-2011. Dhaka.
29. Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9: 737-746.
30. Magee MJ, Bloss E, Shin SS, Contreras C, Huaman HA, et al. (2013) Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru. International Journal of Infectious Diseases 17: e404-412.
31. Bhowmik B, Afsana F, My Diep L, Binte Munir S, Wright E, et al. (2013) Increasing prevalence of type 2 diabetes in a rural bangladeshi population: a population based study for 10 years. Diabetes Metab J 37: 46-53.
32. World Health Organization, International Union against Tuberculsois and Lung Diseases (2011) Collaborative framework for care and control of tuberculosis and diabetes. Geneva.
33. Qazi F, Khan U, Khowaja S, Javaid M, Ahmed A, et al. (2011) Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan. Int J Tuberc Lung Dis 15: 1556-1559.
34. Siddiquea BN, Islam MA, Bam TS, Satyanarayana S, Enarson DA, et al. (2013) High quit rate among smokers with tuberculosis in a modified smoking cessation programme in Dhaka, Bangladesh. Public Health Action 3: 243-246.
35. Brewer TF, Choi HW, Seas C, Krapp F, Zamudio C, et al. (2011) Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment. PLoS ONE 6: e25861.
36. National Institute of Population Research and Training, Mitra and Associates, MEASURE DHS II (2012) Bangladesh Demographic and Health Survey 2011. Dhaka.